Diabetic Macular Edema

TARRYTOWN, N.Y., April 2, 2026 Regeneron Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...

October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...